HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Weak carcinogenicity of 2-hydroxyethyl carbamate in strain A mice: indication that this is not a proximal metabolite of ethyl carbamate.

Abstract
Ethyl carbamate (EC, urethan) is carcinogenic probably because it is converted in vivo to vinyl carbamate and then to vinyl carbamate epoxide, which reacts with DNA bases. We hypothesized that vinyl carbamate arises from EC by oxidation to 2-hydroxy-EC (HEC) and dehydration of the HEC, rather than by direct dehydrogenation of EC. In that case, HEC should be more carcinogenic than EC. In a previous test, HEC showed only borderline initiating activity for mouse skin, but its synthesis was poorly described. In the present study, HEC was synthesized by reacting ethylene carbonate with ammonia and was characterized. A single dose of HEC or EC in saline was injected i.p. into adult male strain A mice, which were maintained for 16 weeks. HEC doses of 1.12, 4.6 and 11.2 mmol/kg induced 0.16, 0.32 and 0.32 lung adenomas/mouse, respectively. The 28% tumor incidence for the two highest doses was significantly (P < 0.05) greater than that in controls injected with saline alone. The number of tumors/mouse with 4.6 mmol HEC/kg was one-fortieth of that for an equimolar dose of EC. The weak activity of HEC supports the view that HEC is not a proximal carcinogenic metabolite of EC, i.e. that vinyl carbamate is produced directly from EC.
AuthorsS S Mirvish, T Smyrk, S Payne, H Tuatoo, S C Chen
JournalCancer letters (Cancer Lett) Vol. 77 Issue 1 Pg. 1-5 (Feb 28 1994) ISSN: 0304-3835 [Print] Ireland
PMID8162558 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Carcinogens
  • Urethane
  • 2-hydroxyethyl carbamate
Topics
  • Animals
  • Biotransformation
  • Carcinogens (metabolism, toxicity)
  • Lung Neoplasms (chemically induced)
  • Male
  • Mice
  • Urethane (analogs & derivatives, metabolism, toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: